Ultroser™ G serum substitute產品介紹：
Ultroser™ G血清替代品可以在細胞培養基中成功替代FCS(胎牛血清)。Ultroser™ G血清替代品設計用于依賴貼壁細胞的體外培養。已在羊膜液細胞原代培養中測試過，旨在確認其核型分析能力。Ultroser G血清替代品通過CE標記注冊。
Ultroser G血清替代品通過一系列質量測試，包括PH、蛋白質濃度、無菌控制、細菌和真菌、牛病毒（BHV1-DVB/MM,紅細胞吸附）、支原體、Hep G2細胞增殖能力、核型分析等。

Ultroser G serum substitute產品特性：
» 半固定成份確保批次間可重現性
» 低蛋白含量
» 方便使用和保藏
» Ultroser G血清替代品濃度是胎牛血清濃度的5倍（2%血清替代品相當于10%胎牛血清）

Ultroser™ G serum substitute英文簡述：
Ultroser™ G serum substitute can successfully replace FCS (fetal calf serum) in cell culture medium. It is designed for the in vitro culture of anchorage-dependent cells. It is specially tested as the primary culture from amniotic liquid cells and is designed to confirm their ability for karyotyping. Ultroser G serum substitute is CE mark-certified.
Ultroser G serum substitute has a concentration five times higher than fetal calf serum (2 % of reconstituted Ultroser G serum substitute is equivalent to 10%  fetal calf serum in the basal medium).

Quality Control Tests
Tests usually performed on Ultroser G serum substitute are:
● Physicochemical parameters pH
● Protein concentration
● Sterility control
● Bacteria & Fungi
● Bovine viruses (BHV1-DVB/MM, hemadsorbents)
● Proliferation capacity on Hep G2
● Mycoplasma
● Karyotyping

華雅再生醫學工程技術有限公司是一家為干細胞研究員提供干細胞無血清培養基，支原體檢測試劑盒，心肌細胞株，人間充質干細胞株，凍存管凍存盒，臍帶間充質干細胞凍存袋，細胞實驗耗材等進口品牌高質量產品。專注干細胞研究，關注干細胞治療產品，購買干細胞產品請到華雅再生醫學工程公司。